Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1996 Nov;70(11):7414–7423. doi: 10.1128/jvi.70.11.7414-7423.1996

Retroviral insertional activation of the c-myb proto-oncogene in a Marek's disease T-lymphoma cell line.

E Le Rouzic 1, B Perbal 1
PMCID: PMC190808  PMID: 8892859

Abstract

Marek's disease virus (MDV) is an avian herpesvirus that causes, in chickens, a lymphoproliferative disease characterized by malignant transformation of T lymphocytes. The rapid onset of polyclonal tumors indicates the existence of MDV-encoded oncogenic products. However, the molecular basis of MDV-induced lymphoproliferative disease and latency remains largely unclear. Several lines of evidence suggest that MDV and Rous-associated virus (RAV) might cooperate in the development of B-cell lymphomas induced by RAV. Our present results indicate for the first time that MDV and RAV might also act synergistically in the development of T-cell lymphomas. We report an example of an MDV-transformed T-lymphoblastoid cell line (T9) expressing high levels of a truncated C-MYB protein as a result of RAV integration within one c-myb allele. The chimeric RAV-c-myb mRNA species initiated in the 5' long terminal repeat of RAV are deprived of sequences corresponding to c-myb exons 1 to 3. The attenuation of MDV oncogenicity has been strongly related to structural changes in the MDV BamHI-D and BamHI-H DNA fragments. We have established that both DNA restriction fragments are rearranged in the T9 MDV-transformed cells. Our results suggest that retroviral insertional activation of the c-myb proto-oncogene is a critical factor involved in the maintenance of the transformed phenotype and the tumorigenic potential of this T-lymphoma cell line.

Full Text

The Full Text of this article is available as a PDF (507.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akiyama Y., Kato S. Two cell lines from lymphomas of Marek's disease. Biken J. 1974 Sep;17(3):105–116. [PubMed] [Google Scholar]
  2. Anderson A. S., Francesconi A., Morgan R. W. Complete nucleotide sequence of the Marek's disease virus ICP4 gene. Virology. 1992 Aug;189(2):657–667. doi: 10.1016/0042-6822(92)90589-h. [DOI] [PubMed] [Google Scholar]
  3. Bacon L. D., Witter R. L., Fadly A. M. Augmentation of retrovirus-induced lymphoid leukosis by Marek's disease herpesviruses in White Leghorn chickens. J Virol. 1989 Feb;63(2):504–512. doi: 10.1128/jvi.63.2.504-512.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Banders U. T., Coussens P. M. Interactions between Marek's disease virus encoded or induced factors and the Rous sarcoma virus long terminal repeat promoter. Virology. 1994 Feb 15;199(1):1–10. doi: 10.1006/viro.1994.1092. [DOI] [PubMed] [Google Scholar]
  5. Belli B., Wolff L., Nazarov V., Fan H. Proviral activation of the c-myb proto-oncogene is detectable in preleukemic mice infected neonatally with Moloney murine leukemia virus but not in resulting end stage T lymphomas. J Virol. 1995 Aug;69(8):5138–5141. doi: 10.1128/jvi.69.8.5138-5141.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Boyle W. J., Lipsick J. S., Reddy E. P., Baluda M. A. Identification of the leukemogenic protein of avian myeloblastosis virus and of its normal cellular homologue. Proc Natl Acad Sci U S A. 1983 May;80(10):2834–2838. doi: 10.1073/pnas.80.10.2834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bradley G., Hayashi M., Lancz G., Tanaka A., Nonoyama M. Structure of the Marek's disease virus BamHI-H gene family: genes of putative importance for tumor induction. J Virol. 1989 Jun;63(6):2534–2542. doi: 10.1128/jvi.63.6.2534-2542.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bradley G., Lancz G., Tanaka A., Nonoyama M. Loss of Marek's disease virus tumorigenicity is associated with truncation of RNAs transcribed within BamHI-H. J Virol. 1989 Oct;63(10):4129–4135. doi: 10.1128/jvi.63.10.4129-4135.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bregni M., Magni M., Siena S., Di Nicola M., Bonadonna G., Gianni A. M. Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer. Blood. 1992 Sep 15;80(6):1418–1422. [PubMed] [Google Scholar]
  10. Calnek B. W. Marek's disease--a model for herpesvirus oncology. Crit Rev Microbiol. 1986;12(4):293–320. doi: 10.3109/10408418509104432. [DOI] [PubMed] [Google Scholar]
  11. Cebrian J., Kaschka-Dierich C., Berthelot N., Sheldrick P. Inverted repeat nucleotide sequences in the genomes of Marek disease virus and the herpesvirus of the turkey. Proc Natl Acad Sci U S A. 1982 Jan;79(2):555–558. doi: 10.1073/pnas.79.2.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chen J. H. Expression of endogenous avian myeloblastosis virus information in different chicken cells. J Virol. 1980 Oct;36(1):162–170. doi: 10.1128/jvi.36.1.162-170.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Chen X. B., Sondermeijer P. J., Velicer L. F. Identification of a unique Marek's disease virus gene which encodes a 38-kilodalton phosphoprotein and is expressed in both lytically infected cells and latently infected lymphoblastoid tumor cells. J Virol. 1992 Jan;66(1):85–94. doi: 10.1128/jvi.66.1.85-94.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Churchill A. E., Chubb R. C., Baxendale W. The attenuation, with loss of oncogenicity, of the herpes-type virus of Marek's disease (strain HPRS-16) on passage in cell culture. J Gen Virol. 1969 Jun;4(4):557–564. doi: 10.1099/0022-1317-4-4-557. [DOI] [PubMed] [Google Scholar]
  15. Churchill A. E., Payne L. N., Chubb R. C. Immunization against Marek's disease using a live attenuated virus. Nature. 1969 Feb 22;221(5182):744–747. doi: 10.1038/221744a0. [DOI] [PubMed] [Google Scholar]
  16. Cleveland D. W., Fischer S. G., Kirschner M. W., Laemmli U. K. Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J Biol Chem. 1977 Feb 10;252(3):1102–1106. [PubMed] [Google Scholar]
  17. Cui Z. Z., Yan D., Lee L. F. Marek's disease virus gene clones encoding virus-specific phosphorylated polypeptides and serological characterization of fusion proteins. Virus Genes. 1990 Apr;3(4):309–322. doi: 10.1007/BF00569038. [DOI] [PubMed] [Google Scholar]
  18. Dini P. W., Lipsick J. S. Oncogenic truncation of the first repeat of c-Myb decreases DNA binding in vitro and in vivo. Mol Cell Biol. 1993 Dec;13(12):7334–7348. doi: 10.1128/mcb.13.12.7334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Dunon D., Schwager J., Dangy J. P., Imhof B. A. Ontogeny of TCR V beta 1 expression revealed novel invariant alternative transcripts. J Immunol. 1995 Feb 1;154(3):1256–1264. [PubMed] [Google Scholar]
  20. Dvorák M., Urbánek P., Bartůnek P., Paces V., Vlach J., Pecenka V., Arnold L., Trávnicek M., Ríman J. Transcription of the chicken myb proto-oncogene starts within a CpG island. Nucleic Acids Res. 1989 Jul 25;17(14):5651–5664. doi: 10.1093/nar/17.14.5651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Eychène A., Marx M., Dezélée P., Calothy G. Complete nucleotide sequence of IC10, a retrovirus containing the Rmil oncogene transduced in chicken neuroretina cells infected with avian retrovirus RAV-1. Nucleic Acids Res. 1989 Feb 11;17(3):1250–1250. doi: 10.1093/nar/17.3.1250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Felder M. P., Laugier D., Yatsula B., Dezélée P., Calothy G., Marx M. Functional and biological properties of an avian variant long terminal repeat containing multiple A to G conversions in the U3 sequence. J Virol. 1994 Aug;68(8):4759–4767. doi: 10.1128/jvi.68.8.4759-4767.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Fukuchi K., Sudo M., Lee Y. S., Tanaka A., Nonoyama M. Structure of Marek's disease virus DNA: detailed restriction enzyme map. J Virol. 1984 Jul;51(1):102–109. doi: 10.1128/jvi.51.1.102-109.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Fukuchi K., Tanaka A., Schierman L. W., Witter R. L., Nonoyama M. The structure of Marek disease virus DNA: the presence of unique expansion in nonpathogenic viral DNA. Proc Natl Acad Sci U S A. 1985 Feb;82(3):751–754. doi: 10.1073/pnas.82.3.751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Fynan E. F., Ewert D. L., Block T. M. Latency and reactivation of Marek's disease virus in B lymphocytes transformed by avian leukosis virus. J Gen Virol. 1993 Oct;74(Pt 10):2163–2170. doi: 10.1099/0022-1317-74-10-2163. [DOI] [PubMed] [Google Scholar]
  26. Fynan E., Block T. M., DuHadaway J., Olson W., Ewert D. L. Persistence of Marek's disease virus in a subpopulation of B cells that is transformed by avian leukosis virus, but not in normal bursal B cells. J Virol. 1992 Oct;66(10):5860–5866. doi: 10.1128/jvi.66.10.5860-5866.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Gerondakis S., Bishop J. M. Structure of the protein encoded by the chicken proto-oncogene c-myb. Mol Cell Biol. 1986 Nov;6(11):3677–3684. doi: 10.1128/mcb.6.11.3677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Gonda T. J., Sheiness D. K., Bishop J. M. Transcripts from the cellular homologs of retroviral oncogenes: distribution among chicken tissues. Mol Cell Biol. 1982 Jun;2(6):617–624. doi: 10.1128/mcb.2.6.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Grässer F. A., Graf T., Lipsick J. S. Protein truncation is required for the activation of the c-myb proto-oncogene. Mol Cell Biol. 1991 Aug;11(8):3987–3996. doi: 10.1128/mcb.11.8.3987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Hayward W. S., Neel B. G., Astrin S. M. Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis. Nature. 1981 Apr 9;290(5806):475–480. doi: 10.1038/290475a0. [DOI] [PubMed] [Google Scholar]
  31. Jones D., Lee L., Liu J. L., Kung H. J., Tillotson J. K. Marek disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors. Proc Natl Acad Sci U S A. 1992 May 1;89(9):4042–4046. doi: 10.1073/pnas.89.9.4042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kanei-Ishii C., MacMillan E. M., Nomura T., Sarai A., Ramsay R. G., Aimoto S., Ishii S., Gonda T. J. Transactivation and transformation by Myb are negatively regulated by a leucine-zipper structure. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):3088–3092. doi: 10.1073/pnas.89.7.3088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Kanter M. R., Smith R. E., Hayward W. S. Rapid induction of B-cell lymphomas: insertional activation of c-myb by avian leukosis virus. J Virol. 1988 Apr;62(4):1423–1432. doi: 10.1128/jvi.62.4.1423-1432.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Kawamura M., Hayashi M., Furuichi T., Nonoyama M., Isogai E., Namioka S. The inhibitory effects of oligonucleotides, complementary to Marek's disease virus mRNA transcribed from the BamHI-H region, on the proliferation of transformed lymphoblastoid cells, MDCC-MSB1. J Gen Virol. 1991 May;72(Pt 5):1105–1111. doi: 10.1099/0022-1317-72-5-1105. [DOI] [PubMed] [Google Scholar]
  35. Klempnauer K. H., Arnold H., Biedenkapp H. Activation of transcription by v-myb: evidence for two different mechanisms. Genes Dev. 1989 Oct;3(10):1582–1589. doi: 10.1101/gad.3.10.1582. [DOI] [PubMed] [Google Scholar]
  36. Klempnauer K. H., Gonda T. J., Bishop J. M. Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: the architecture of a transduced oncogene. Cell. 1982 Dec;31(2 Pt 1):453–463. doi: 10.1016/0092-8674(82)90138-6. [DOI] [PubMed] [Google Scholar]
  37. Klempnauer K. H., Ramsay G., Bishop J. M., Moscovici M. G., Moscovici C., McGrath J. P., Levinson A. D. The product of the retroviral transforming gene v-myb is a truncated version of the protein encoded by the cellular oncogene c-myb. Cell. 1983 Jun;33(2):345–355. doi: 10.1016/0092-8674(83)90416-6. [DOI] [PubMed] [Google Scholar]
  38. Kryceve-Martinerie C., Soret J., Crochet J., Baluda M., Perbal B. Expression of a truncated v-myb product in transformed chicken embryo fibroblasts. FEBS Lett. 1987 Apr 6;214(1):81–86. doi: 10.1016/0014-5793(87)80017-0. [DOI] [PubMed] [Google Scholar]
  39. Lüscher B., Christenson E., Litchfield D. W., Krebs E. G., Eisenman R. N. Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activation. Nature. 1990 Apr 5;344(6266):517–522. doi: 10.1038/344517a0. [DOI] [PubMed] [Google Scholar]
  40. Lüscher B., Eisenman R. N. New light on Myc and Myb. Part II. Myb. Genes Dev. 1990 Dec;4(12B):2235–2241. doi: 10.1101/gad.4.12b.2235. [DOI] [PubMed] [Google Scholar]
  41. MacLeod A. R. Expression of the mRNA coding for glyceraldehyde-3-phosphate dehydrogenase. Eur J Biochem. 1981 Oct;119(2):353–358. doi: 10.1111/j.1432-1033.1981.tb05615.x. [DOI] [PubMed] [Google Scholar]
  42. Maotani K., Kanamori A., Ikuta K., Ueda S., Kato S., Hirai K. Amplification of a tandem direct repeat within inverted repeats of Marek's disease virus DNA during serial in vitro passage. J Virol. 1986 May;58(2):657–660. doi: 10.1128/jvi.58.2.657-660.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Merzak A., Soret J., Martinerie C., Sureau A., Crochet J., Perbal B. Transforming potential of truncated v-myb and stimulation of replication by gag-myb fusion products. Oncogene. 1992 Mar;7(3):535–542. [PubMed] [Google Scholar]
  44. Moelling K., Pfaff E., Beug H., Beimling P., Bunte T., Schaller H. E., Graf T. DNA-binding activity is associated with purified myb proteins from AMV and E26 viruses and is temperature-sensitive for E26 ts mutants. Cell. 1985 Apr;40(4):983–990. doi: 10.1016/0092-8674(85)90358-7. [DOI] [PubMed] [Google Scholar]
  45. Mukhopadhyaya R., Wolff L. New sites of proviral integration associated with murine promonocytic leukemias and evidence for alternate modes of c-myb activation. J Virol. 1992 Oct;66(10):6035–6044. doi: 10.1128/jvi.66.10.6035-6044.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Mushinski J. F., Potter M., Bauer S. R., Reddy E. P. DNA rearrangement and altered RNA expression of the c-myb oncogene in mouse plasmacytoid lymphosarcomas. Science. 1983 May 20;220(4599):795–798. doi: 10.1126/science.6687762. [DOI] [PubMed] [Google Scholar]
  47. Nason-Burchenal K., Wolff L. Activation of c-myb is an early bone-marrow event in a murine model for acute promonocytic leukemia. Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1619–1623. doi: 10.1073/pnas.90.4.1619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Nazarov V., Wolff L. Novel integration sites at the distal 3' end of the c-myb locus in retrovirus-induced promonocytic leukemias. J Virol. 1995 Jun;69(6):3885–3888. doi: 10.1128/jvi.69.6.3885-3888.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Neel B. G., Gasic G. P., Rogler C. E., Skalka A. M., Ju G., Hishinuma F., Papas T., Astrin S. M., Hayward W. S. Molecular analysis of the c-myc locus in normal tissue and in avian leukosis virus-induced lymphomas. J Virol. 1982 Oct;44(1):158–166. doi: 10.1128/jvi.44.1.158-166.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Okazaki W., Purchase H. G., Burmester B. R. Protection against Marek's disease by vaccination with a herpesvirus of turkeys. Avian Dis. 1970 May;14(2):413–429. [PubMed] [Google Scholar]
  51. Perbal B., Baluda M. A. Avian myeloblastosis virus transforming gene is related to unique chicken DNA regions separated by at least one intervening sequence. J Virol. 1982 Jan;41(1):250–257. doi: 10.1128/jvi.41.1.250-257.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Perbal B., Baluda M. A. Organization of chicken DNA sequences homologous to the transforming gene of avian myeloblastosis virus. I. Restriction enzyme analysis of total DNA from normal and leukemic cells. J Virol. 1982 Nov;44(2):586–594. doi: 10.1128/jvi.44.2.586-594.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Perbal B., Cline J. M., Hillyard R. L., Baluda M. A. Organization of chicken DNA sequences homologous to the transforming gene of avian myeloblastosis virus. II. Isolation and characterization of lambda proto-amv DNA recombinant clones from a library of leukemic chicken DNA. J Virol. 1983 Mar;45(3):925–940. doi: 10.1128/jvi.45.3.925-940.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Perbal B., Lipsick J. S., Svoboda J., Silva R. F., Baluda M. A. Biologically active proviral clone of myeloblastosis-associated virus type 1: implications for the genesis of avian myeloblastosis virus. J Virol. 1985 Oct;56(1):240–244. doi: 10.1128/jvi.56.1.240-244.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Pizer E., Humphries E. H. RAV-1 insertional mutagenesis: disruption of the c-myb locus and development of avian B-cell lymphomas. J Virol. 1989 Apr;63(4):1630–1640. doi: 10.1128/jvi.63.4.1630-1640.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Pratt W. D., Cantello J., Morgan R. W., Schat K. A. Enhanced expression of the Marek's disease virus-specific phosphoproteins after stable transfection of MSB-1 cells with the Marek's disease virus homologue of ICP4. Virology. 1994 May 15;201(1):132–136. doi: 10.1006/viro.1994.1273. [DOI] [PubMed] [Google Scholar]
  57. Press R. D., Kim A., Ewert D. L., Reddy E. P. Transformation of chicken myelomonocytic cells by a retrovirus expressing the v-myb oncogene from the long terminal repeats of avian myeloblastosis virus but not Rous sarcoma virus. J Virol. 1992 Sep;66(9):5373–5383. doi: 10.1128/jvi.66.9.5373-5383.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Pulaski J. T., Tieber V. L., Coussens P. M. Marek's disease virus-mediated enhancement of avian leukosis virus gene expression and virus production. Virology. 1992 Jan;186(1):113–121. doi: 10.1016/0042-6822(92)90065-w. [DOI] [PubMed] [Google Scholar]
  59. Roizmann B., Desrosiers R. C., Fleckenstein B., Lopez C., Minson A. C., Studdert M. J. The family Herpesviridae: an update. The Herpesvirus Study Group of the International Committee on Taxonomy of Viruses. Arch Virol. 1992;123(3-4):425–449. doi: 10.1007/BF01317276. [DOI] [PubMed] [Google Scholar]
  60. Ross N., Binns M. M., Sanderson M., Schat K. A. Alterations in DNA sequence and RNA transcription of the Bam HI-H fragment accompany attenuation of oncogenic Marek's disease herpesvirus. Virus Genes. 1993 Feb;7(1):33–51. doi: 10.1007/BF01702347. [DOI] [PubMed] [Google Scholar]
  61. Rushlow K. E., Lautenberger J. A., Papas T. S., Baluda M. A., Perbal B., Chirikjian J. G., Reddy E. P. Nucleotide sequence of the transforming gene of avian myeloblastosis virus. Science. 1982 Jun 25;216(4553):1421–1423. doi: 10.1126/science.6283631. [DOI] [PubMed] [Google Scholar]
  62. Sakura H., Kanei-Ishii C., Nagase T., Nakagoshi H., Gonda T. J., Ishii S. Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene. Proc Natl Acad Sci U S A. 1989 Aug;86(15):5758–5762. doi: 10.1073/pnas.86.15.5758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Schat K. A., Chen C. L., Calnek B. W., Char D. Transformation of T-lymphocyte subsets by Marek's disease herpesvirus. J Virol. 1991 Mar;65(3):1408–1413. doi: 10.1128/jvi.65.3.1408-1413.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Shen-Ong G. L. The myb oncogene. Biochim Biophys Acta. 1990 Jun 1;1032(1):39–52. doi: 10.1016/0304-419x(90)90011-o. [DOI] [PubMed] [Google Scholar]
  65. Soret J., Kryceve-Martinerie C., Crochet J., Perbal B. Transformation of Brown Leghorn chicken embryo fibroblasts by avian myeloblastosis virus proviral DNA. J Virol. 1985 Jul;55(1):193–205. doi: 10.1128/jvi.55.1.193-205.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Soret J., Vellard M., Martinerie C., Perbal B. Organization of 5'-proximal c-myb exons in chicken DNA. Implications for c-myb tissue-specific transcription. FEBS Lett. 1988 May 9;232(1):227–234. doi: 10.1016/0014-5793(88)80422-8. [DOI] [PubMed] [Google Scholar]
  67. Soret J., Vellard M., Viegas-Pequignot E., Apiou F., Dutrillaux B., Perbal B. Chromosomal reallocation of the chicken c-myb locus and organization of 3'-proximal coding exons. FEBS Lett. 1990 Apr 24;263(2):254–260. doi: 10.1016/0014-5793(90)81387-4. [DOI] [PubMed] [Google Scholar]
  68. Sureau A., Soret J., Vellard M., Crochet J., Perbal B. The PR264/c-myb connection: expression of a splicing factor modulated by a nuclear protooncogene. Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11683–11687. doi: 10.1073/pnas.89.24.11683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Tieber V. L., Zalinskis L. L., Silva R. F., Finkelstein A., Coussens P. M. Transactivation of the Rous sarcoma virus long terminal repeat promoter by Marek's disease virus. Virology. 1990 Dec;179(2):719–727. doi: 10.1016/0042-6822(90)90139-i. [DOI] [PubMed] [Google Scholar]
  70. Westin E. H., Gallo R. C., Arya S. K., Eva A., Souza L. M., Baluda M. A., Aaronson S. A., Wong-Staal F. Differential expression of the amv gene in human hematopoietic cells. Proc Natl Acad Sci U S A. 1982 Apr;79(7):2194–2198. doi: 10.1073/pnas.79.7.2194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Whitcomb J. M., Hughes S. H. Retroviral reverse transcription and integration: progress and problems. Annu Rev Cell Biol. 1992;8:275–306. doi: 10.1146/annurev.cb.08.110192.001423. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES